Board

Board of directors

Chairman, M.B.A.

Max Pihlqvist

Max Pihlqvist has a master’s degree in business administration from Lund University and significant experience in the laboratory and diagnostics industry. Max Pihlqvist has previous experience from IDL Biotech as a board member during the years 2017-2019.

Today, Max works as CEO of the Svenska Labex AB Group with subsidiaries in Norway and Denmark and is Chairman of the Board of Labbex forvaltnings AB, Norsk Labex AS, Labex APS and Labex Reagens AB.

Board member since 2022

Holdings in IDL Diagnostics: 44,411,786 privately and through companies

Dependent in relation to one of the company’s major owners.

Ph.D.

Eva Nordström

Eva has a Ph.D. in immunology under Prof. Erna Möller at Stockholm University and is currently working as a Senior Researcher at BioArctic AB. She has wide scientific experience from assay development, hybridoma generation and immunoassays.

Board member since 2020

Holdings in IDL Diagnostics: 120,000 shares.

Independent in relation to the company and its management and in relation to major shareholders.

B.S.Chem.

Agneta Tufvesson Alm

Agneta Tufvesson Alm has more than 30 years of experience in international sales and marketing as well as experience in direct sales in the Nordic countries and the United Kingdom, region and key account management in Europe, Africa, and the Middle East. Agneta has worked with building distribution networks, contract negotiations, and management of sales and customer service teams. She currently works at Kemira Kemi AB and has previously held roles at HemoCue AB, Thermo Quest, and Kabi Pharmacia. Agneta has a bachelor’s degree in chemistry from Lund University.

Board member since 2022

Holdings in IDL Diagnostics: 20,000 shares

Independent in relation to the company and its management and in relation to major shareholders.

MD, PhD, Professor Urologic oncology

Per-Anders Abrahamsson

Per-Anders Abrahamsson has a Professorship in urologic oncology from Lund University.

Other current assignments: Board member of Guldlyckan AB, Perituskliniken AB, and Medisport Holding AB.

Previous assignments: Chairman of the board and board member of Uptake Bio AB and former board member of AroCell AB (publ). Clinic manager in Malmö and Lund for 20 years and Secretary General of the world-leading scientific organization European Association of Urology from 2007 to 2015.

Holdings in IDL Diagnostics: Nil shares

Independent in relation to the company and its management and in relation to major shareholders.

BSc

Clas Runnberg

Clas is also currently Chairman of the board of Svenska Labex AB.

Previously he was a board member of Adenovir Pharma AB, chairman of the board of P.U.L.S. AB (now Aqilon AB). Higher positions in marketing at Viggo AB, Gambro AB, and HemoCue AB as well as corporate management and strategic business development at Diatek Medical Technologies, CA, USA and Block Medical, CA, USA.

Clas has a diploma in marketing economics from Marketing Association/Lund University.

Board member since 2023

Holdings in IDL Diagnostics: 250,761 shares

Independent in relation to the company and its management and in relation to major shareholders.

About us

We provide knowledge to decision.

IDL Diagnosticsis a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.

Bacteriology

An effective typhoid test

Typhoid fever is water and food-borne infectious disease caused by the bacterium, Salmonella enterica. IDL Biotechs product TUBEX® TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.

Oncology

Diagnostics for oncology

Cancer is one of the leading causes of death worldwide, despite advancing knowledge. To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.

Board

Board of directors